Gene activity in ankylosing spondylitis and psoriatic arthritis
Part of Bones, joints & muscles clinical trials.
This study looks at a specific gene (TNFAIP3) that may affect inflammation in two types of arthritis: ankylosing spondylitis (which affects the spine) and psoriatic arthritis (which often comes with psoriasis). The goal is to see if this gene relates to how active the disease is, which might help understand these conditions better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a diagnosis of ankylosing spondylitis (confirmed by a doctor using standard criteria) or psoriatic arthritis (also confirmed by a doctor).
- You are not pregnant or breastfeeding.
- You do not have other autoimmune diseases (like lupus) or major health conditions.
- You are not taking immunosuppressive drugs (medications that weaken the immune system).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a body signal called IL-23 may drive inflammation in spondyloarthritis (including joints) using samples from your care. It may help researchers identify which body cells and targets are involved, and how treatments could work better for active disease.
This study looks at how psoriatic arthritis affects your daily life and how that relates to the severity of your condition. It aims to better understand the disease to improve future care.
This study looks at treatments for people with ankylosing spondylitis, a type of arthritis that affects the spine. It aims to find better ways to manage symptoms and improve quality of life.
This study follows people with spondyloarthritis (an inflammatory arthritis that often affects the spine and joints) and their family members over time to better understand how the disease develops and progresses. It also includes a research stool sample test to learn about gut bacteria.
This study enrolls people who have recently been diagnosed with certain inflammatory conditions affecting the spine, joints, or the eye. Researchers are looking to better understand how these illnesses start and how they may be linked, which could help guide future care.
This study looks at how inflammatory “cytokines” are expressed in people with psoriasis—both those with joint involvement and those without. It may help researchers understand what drives joint disease and guide better future monitoring or treatments.
Hear when a new Ankylosing Spondylitis and Psoriatic Arthritis Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.